4//SEC Filing
Lackner Mark 4
Accession 0001725160-25-000002
CIK 0001725160other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:17 PM ET
Size
5.1 KB
Accession
0001725160-25-000002
Insider Transaction Report
Form 4
Lackner Mark
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-01-02$3.12/sh−4,411$13,762→ 191,317 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001777413
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:17 PM ET
- Size
- 5.1 KB